International Clinical Trial: Speech Therapy for Children With Rare Genetic Conditions and Childhood Apraxia of Speech

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815249) titled 'Speech Therapy for Children With Rare Genetic Conditions and Childhood Apraxia of Speech' on Sept. 6.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Murdoch Childrens Research Institute

Condition: Childhood Apraxia of Speech Genetic Condition

Intervention: Behavioral: Rapid Syllable Transition Treatment

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: July 1, 2026

Target Sample Size: 20

Countries of Recruitment: Australia

To know more, visit https://clini...